Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Frankrijk
  4. Euronext Paris
  5. Inventiva
  6. Nieuws
  7. Persberichten
    IVA   FR0013233012

INVENTIVA

(IVA)
  Rapport
Real Time Euronext Paris  -  17:35 05-12-2022
4.385 EUR   +5.41%
29/11Inventiva krijgt nieuw Amerikaans octrooi voor geneesmiddel tegen leverziekten
MT
21/11Inventiva kondigt Lucy Lu aan als bestuurder van haar Raad van Bestuur
CI
07/11Europese ADR's stijgen in de maandagse handel
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť INVENTIVA
28/11Inventiva secures a new patent expanding the IP protection of its lead product candidat..
GL
28/11Inventiva secures a new patent expanding the IP protection of its lead product candidat..
AQ
21/11Inventiva announces a new Director of the Board of Directors
GL
21/11Inventiva announces a new Director of the Board of Directors
AQ
11/11Inventiva reports 2022 Third Quarter Financial Information
AQ
10/11Inventiva reports 2022 Third Quarter Financial InformationĻ
GL
10/11Inventiva reports 2022 Third Quarter Financial InformationĻ
AQ
31/10Inventiva provides an update on the development of cedirogant by AbbVie
GL
31/10Inventiva provides an update on the development of cedirogant by AbbVie
AQ
24/10Inventiva announces a scientific presentation at the AASLD the Liver Meeting 2022
AQ
21/10Inventiva announces a scientific presentation at the AASLD The Liver Meetingģ 2022
GL
21/10Inventiva announces a scientific presentation at the AASLD The Liver Meetingģ 2022
AQ
05/10Inventiva : Présentation corporate Octobre 2022
PU
04/10Inventiva : Corporate presentation October 2022
PU
28/09Inventiva : (INDICATED BY ) HAS BEEN OMITTED PURSUANT TO ITEM 601(B)(10) OF REGULATION S-K..
PU
22/09Inventiva reports its 2022 first-half financial results and provides a corporate update
GL
22/09Inventiva reports its 2022 first-half financial results and provides a corporate update
AQ
21/09Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop a..
GL
21/09Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop a..
AQ
07/09Inventiva : 2022 First-Half Financial Results Presentation
PU
07/09Inventiva announces the schedule of publication and presentation of its 2022 Half-Year ..
GL
07/09Inventiva announces the schedule of publication and presentation of its 2022 Half-Year ..
AQ
01/09Inventiva : Corporate presentation September 2022
PU
28/07Inventiva : Reports 2022 First-Half Financial Informationˆ - Form 6-K
PU
28/07Inventiva Reports 2022 First-Half Financial InformationĻ
GL
28/07Inventiva Reports 2022 First-Half Financial InformationĻ
AQ
21/07Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux
GL
21/07Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux
AQ
07/07Inventiva announces the screening of the first patient in LEGEND, a Phase IIa combinati..
GL
07/07Inventiva announces the screening of the first patient in LEGEND, a Phase IIa combinati..
AQ
05/07Inventiva - Update on Inventiva's cash position and on the finance documentation with t..
AQ
05/07Inventiva : Update on Inventiva's cash position and on the finance documentation with the ..
PU
04/07Inventiva : At-the-market program allowing the issuance of ordinary shares in the form of ..
PU
04/07Update on Inventiva's cash position and on the finance documentation with the European ..
GL
04/07Update on Inventiva's cash position and on the finance documentation with the European ..
AQ
16/06Inventiva to host a webcast with Key Opinion Leaders following the EASL International L..
GL
16/06Inventiva to host a webcast with Key Opinion Leaders following the EASL International L..
AQ
10/06Inventiva announces three scientific presentations at the EASL International Liver Cong..
AQ
09/06Inventiva announces three scientific presentations at the EASL International Liver Cong..
GL
09/06Inventiva announces three scientific presentations at the EASL International Liver Cong..
AQ
07/06Inventiva joins the Euronext Tech Leaders segment
GL
06/06Inventiva announces the presentation of a scientific abstract at the 82nd Scientific Se..
AQ
03/06Inventiva : announces the presentation of a scientific abstract at the 82nd Scientific Ses..
PU
03/06†Inventiva announces the presentation of a scientific abstract at the 82nd Scientific S..
GL
03/06†Inventiva announces the presentation of a scientific abstract at the 82nd Scientific S..
AQ
02/06Inventiva : Présentation Corporate Juin 2022
PU
24/05Iran may be heartbeat away from first unicorn
AQ
23/05Inventiva announces participation at several investors conferences in May and June 2022
GL
23/05Inventiva announces participation at several investors conferences in May and June 2022
AQ
23/05Inventiva - Results of the votes of the Combined Shareholders' Meeting of May 19, 2022
AQ
20/05Inventiva : Results of the votes of the Combined Shareholders' Meeting of May 19, 2022
PU
20/05Inventiva : Results of the votes of the Combined Shareholders' Meeting of May 19, 2022 - F..
PU
20/05Inventiva : Résultat des votes de l'Assemblée Générale Mixte du 19 mai 2022
PU
20/05Results of the votes of the Combined Shareholders' Meeting of May 19, 2022
GL
20/05Results of the votes of the Combined Shareholders' Meeting of May 19, 2022
GL
20/05Inventiva - Description of the share repurchase program authorised by the Ordinary Gene..
AQ
19/05Description of the Share Repurchase Program Authorised by the Ordinary General Meeting ..
GL
17/05Inventiva secures a EUR50 million credit facility from the European Investment Bank
AQ
16/05Inventiva reports 2022 First Quarter Financial Information and provides clinical develo..
GL
16/05Inventiva reports 2022 First Quarter Financial Information and provides clinical develo..
AQ
16/05Inventiva secures a Ä50 million credit facility from the European Investment Bank
GL
28/04Inventiva : Availability of the preparatory documents - Form 6-K
PU
28/04Inventiva : Board report to the SGM about proposed resolutions
PU
28/04Combined General Meeting of May 19, 2022 - Availability of the preparatory documents
AQ
28/04Inventiva : Combined General Meeting of May 19, 2022 Availability of the preparatory docum..
PU
25/04Inventiva : Supplementary report of the board of directors of April 16, 2021 following the..
PU
25/04Inventiva : Draft text of the resolutions
PU
11/04Inventiva : Notice of meeting to the Ordinary and Extraordinary General Meeting dated May ..
PU
11/04Inventiva : Notice of meeting to the Ordinary and Extraordinary General Meeting dated May ..
PU
08/04Inventiva announces the presentation of a scientific abstract at the next International..
AQ
07/04†Inventiva announces the presentation of a scientific abstract at the next Internationa..
AQ
14/03Inventiva announces filing of its 2021 Universal Registration Document and 2021 Annual ..
AQ
11/03†Inventiva announces filing of its 2021 Universal Registration Document and 2021 Annual..
GL
11/03Inventiva : announces filing of its 2021 Universal Registration Document and 2021 Annual R..
PU
10/03Inventiva : Corporate Presentation March 2022
PU
1  2  3  4  5  6Volgende
Volgende evenement op INVENTIVA